4//SEC Filing
Tatsis Ourania 4
Accession 0000875320-25-000095
CIK 0000875320other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:36 PM ET
Size
6.1 KB
Accession
0000875320-25-000095
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Tax Payment
Common Stock
2025-02-14$463.46/sh−2,293$1,062,714→ 67,939 total - Sale
Common Stock
2025-02-18$455.06/sh−244$111,035→ 67,695 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001789815
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:36 PM ET
- Size
- 6.1 KB